Delivery Order SPE2DB22D2206-SPE2DB23FEG31
Award Date
11/28/22
Potential Completion Date
12/19/22
Potential Value
$171K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $102,812.74 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 5 MG CAPSULE 28S pharmaceutical products. The order was placed under an existing Department of Defense contract vehicle and is expected to be completed by September 28, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of supplying pharmaceuticals and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,281.49 firm fixed price delivery order is for the provision of REVLIMID 25 MG CAPSULE 21S pharmaceutical products. The contract has no set-aside designation and the performance location is Amerisourcebergen's corporate headquarters in Conshohocken,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order to supply Revlimid 10 mg capsules, a specialty pharmaceutical product, with a potential value of $27,859.78. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp, through its Corporate...
Amerisourcebergen Drug Corp has received a $56,490.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply REVLIMID 10 MG CAPSULE 28S pharmaceutical products. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified medications to DLA Troop Support Medical facilities in support of military treatment programs. This delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REVLIMID 10 MG CAPSULE 100S. The firm fixed price contract has a potential value of $106,870.16 and a completion date of June 16, 2022. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its corporate office location in Conshohocken, Pennsylvania. No set-aside...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $178,310.12, is for the supply of REVLIMID 5 MG CAPSULE 100S, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $227,924.70 firm fixed price contract is for the delivery of REVLIMID 10 MG CAPSULE 100S pharmaceutical products. The contract has an end date of October 14, 2022 and was awarded on September 22, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government...
The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order to supply REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $192,510.80. This award was not set aside for any specific business type. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,649.37, is a Delivery Order contract for the supply of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025 and is a Firm Fixed Price contract. There is no set-aside designation associated with this award. AmerisourceBergen...